This is the first study showing the beneficial effects of a diuretic added to a combination of the RAS inhibitors and endothelin receptor A antagonist atrasentan in a model of CKD which was induced by subtotal nephrectomy in hypertensive heterozygous Ren-2 transgenic rats. The gene discussed is REN; the disease is chronic kidney disease.